Skip to search formSkip to main contentSkip to account menu

frovatriptan

Known as: 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, frovatriptan [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Migraine might be associated with high blood pressure (BP), which can cause more severe and more difficult to treat forms of… 
Review
2011
Review
2011
Introduction: Migraine is the most common painful neurological disorder, affecting 13% of the general population. Triptans… 
Review
2011
Review
2011
The text presents a systematic approach to diagnosis, and is rich with expert recommendations for treating all types of headaches… 
2010
2010
IntroductionLarge postmarketing surveillance (PMS) studies have demonstrated the efficacy and tolerability of frovatriptan for… 
2010
2010
Abstract Objectives: Compare migraine duration with frovatriptan (versus baseline) in migraineurs reporting long- (24−72 h) or… 
2009
2009
BACKGROUND The chronic nature of migraine and the reliance on acute treatment constitute the basis of the present long-term, open… 
Review
2005
Review
2005
Many women experience headaches, including migraine, in association with their menstrual cycles. Although definitions vary… 
2001
2001
The effects of frovatriptan and sumatriptan on internal carotid and coronary vascular haemodynamics were investigated and… 
1998
1998
The effects of frovatriptan (VML 251/SB-209509) on coronary artery function were investigated in isolated coronary arteries from…